This topic contains a solution. Click here to go to the answer

Author Question: How does propranolol (Inderal) control hypertension? a. Blocks alpha receptors throughout the ... (Read 35 times)

mydiamond

  • Hero Member
  • *****
  • Posts: 804
How does propranolol (Inderal) control hypertension?
 
  a. Blocks alpha receptors throughout the body
  b. Increases the diuretic response in the renal tubules
  c. Reduces the sympathetic stimulation in cardiac muscle
  d. Inhibits the conversion of angiotensin I to angiotensin II

Question 2

The nurse is preparing to administer niacin for the first time to a patient being treated for dyslipidemia. Before administering this medication, the nurse will assess (Select all that apply.)
 
  a. blood glucose levels.
  b. blood pressure.
  c. heart rate.
  d. temperature.
  e. oxygen saturation.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bimper21

  • Sr. Member
  • ****
  • Posts: 309
Answer to Question 1

ANS: C
The beta-adrenergic blocking agents block beta receptor stimulation in the heart, which then inhibits cardiac response to sympathetic nerve stimulation. This results in a decrease in heart rate, cardiac output, and blood pressure. Beta blockers do not affect alpha receptors. Beta blockers do not have a diuretic effect. ACE inhibitors are in the class of drugs that affects angiotensin conversion.

Answer to Question 2

ANS: A, B, C
Baseline blood glucose, blood pressure, and heart rate should be determined before initiating niacin therapy. Temperature and oxygen saturation levels are not necessary prior to administering niacin.




bimper21

  • Sr. Member
  • ****
  • Posts: 309

 

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Bacteria have been found alive in a lake buried one half mile under ice in Antarctica.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Approximately 500,000 babies are born each year in the United States to teenage mothers.

Did you know?

Eating food that has been cooked with poppy seeds may cause you to fail a drug screening test, because the seeds contain enough opiate alkaloids to register as a positive.

For a complete list of videos, visit our video library